Delivery Order SPE2DB20D3103-SPE2DB25FP6L5
- Not listed
- This is a $1,055.28 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the PEDVAXHIB vaccine in 0.5 mL vials, with a completion date of September 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,377.16 contract is for the delivery of PEDVAXHIB vaccine vials to support military treatment programs and facilities. This award is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the PEDVAXHIB vaccine in 0.5 milliliter vials. The $2,405.65 contract has a completion date of June 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that enables the company to supply a wide range of pharmaceutical products and...
- The Defense Logistics Agency Troop Support Medical awarded a $700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PEDVAXHIB vaccine vials. The single vial, 0.5mL quantity vaccines will be delivered to a location in Conshohocken, Pennsylvania by August 22, 2023 to support DLA's medical supply needs. Amerisourcebergen will serve as the prime contractor, with no subcontractors mentioned. As a key distributor of pharmaceuticals and medical supplies for the Department of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract, valued at $1,080.58, is for the supply of PEDVAXHIB VACCINE VIAL 0.5ML. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, serves as a prime contractor providing a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency Troop Support Medical awarded a $1,576.98 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561445439 PEDVAXHIB vaccine vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver 0.5mL vials of the PEDVAXHIB vaccine from its place of performance in Conshohocken, Pennsylvania. The delivery order was issued on July 10, 2023 under an existing Amerisourcebergen Corporation indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,636.50 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the provision of PEDVAXHIB vaccine vials and has a completion date of February 14, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDVAXHIB vaccine vials. The contract has a potential value of $6,447.60 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under any set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,928.42 firm fixed-price contract is for the supply of the PEDVAXHIB vaccine in 0.5 ml vials. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various federal agencies and healthcare programs. This order is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6L5Delivery Order
The Defense Logistics Agency awarded a $1,859.50 delivery order to AmerisourceBergen Drug Corp for PEDVAXHIB vaccine vials (0.5 mL) with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded on July 25, 2025, with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. AmerisourceBergen's prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems globally. This delivery order for PEDVAXHIB vaccine aligns with the broader contract scope supporting Defense Health Agency operations and other federal healthcare systems. The firm's extensive federal procurement portfolio demonstrates its capability to fulfill critical medical supply needs across multiple therapeutic domains, with delivery orders typically involving firm fixed pricing arrangements ranging from minimal to substantial values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/25/25 |